Hims & Hers Health (HIMS) has been one of the market’s standout growth stocks in recent years. The company has successfully built a direct-to-consumer health platform targeting conditions like hair ...
2mon
3 reasons digital-healthcare pioneer Hims is staying out of the latest weight-loss craze for now
Hims & Hers wants to launch its own weight loss program with GLP-1s like Ozempic. CEO Andrew Dudum worries about three challenges to the new market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback